Putnam BioRevolution ETF (SYNB)

Assets	$4.87M
Expense Ratio	0.71%
PE Ratio	28.62
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.77%
Ex-Dividend Date	Dec 5, 2024
Payout Ratio	22.13%
1-Year Return	-11.91%

Volume	n/a
Open	27.91
Previous Close	27.67
Day's Range	27.91 - 27.91
52-Week Low	24.57
52-Week High	33.23
Beta	0.94
Holdings	37
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

49.86% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	7.31%
Novozymes A/S	NVZMY	5.54%
Corteva, Inc.	CTVA	5.54%
AbbVie Inc.	ABBV	5.39%
Bio-Rad Laboratories, Inc.	BIO	5.12%
Eli Lilly and Company	LLY	4.62%
Ascendis Pharma A/S	ASND	4.45%
AstraZeneca PLC	AZN	4.36%
NVIDIA Corporation	NVDA	3.80%
Cadence Design Systems, Inc.	CDNS	3.73%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.2139	Dec 9, 2024
Dec 6, 2023	$0.0211	Dec 11, 2023